Development of novel METAP2 inhibitors as potential therapeutics for microsporidiosis
Ended Project Grant Awarded Last action
- Award ID
- R01AI132614
- Recipient
-
Long Island University UEI NQF1RQMMQAN7 Part of Long Island University
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,337,813
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$128,063 | |
| Amendment | $401,250 | |
| Amendment | $390,001 | |
| Amendment | $401,250 | |
| Amendment | -$226,113 | |
| Amendment | $226,113 | |
| Amendment | $414,750 | |
| Amendment | $0 | |
| Amendment | $420,625 | |
| Amendment | $0 | |
| Original award | $438,000 |
Show all 11
Quick answers
Who received award R01AI132614?
R01AI132614 was awarded to Long Island University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 26, 2018.
How much is award R01AI132614 worth?
$2,337,813 has been obligated on R01AI132614.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award